EGFR signaling in liver diseases
K Komposch, M Sibilia - International journal of molecular sciences, 2015 - mdpi.com
The epidermal growth factor receptor (EGFR) is a transmembrane receptor tyrosine kinase
that is activated by several ligands leading to the activation of diverse signaling pathways …
that is activated by several ligands leading to the activation of diverse signaling pathways …
The epidermal growth factor receptor: a link between inflammation and liver cancer
C Berasain, MJ Perugorria, MU Latasa… - Experimental …, 2009 - journals.sagepub.com
Epidemiological studies have established that many tumours occur in association with
persistent inflammation. One clear example of inflammation-related cancer is hepatocellular …
persistent inflammation. One clear example of inflammation-related cancer is hepatocellular …
The EGFR signalling system in the liver: from hepatoprotection to hepatocarcinogenesis
C Berasain, MA Avila - Journal of gastroenterology, 2014 - Springer
The liver displays an outstanding wound healing and regenerative capacity unmatched by
any other organ. This reparative response is governed by a complex network of …
any other organ. This reparative response is governed by a complex network of …
The EGF receptor is required for efficient liver regeneration
A Natarajan, B Wagner… - Proceedings of the …, 2007 - National Acad Sciences
Mice lacking the EGF receptor (EGFR) die between midgestation and postnatal day 20 with
various defects in neural and epithelial organs. Here, we generated mice carrying a floxed …
various defects in neural and epithelial organs. Here, we generated mice carrying a floxed …
Epidermal growth factor receptor (EGFR) crosstalks in liver cancer
C Berasain, MU Latasa, R Urtasun, S Goñi, M Elizalde… - Cancers, 2011 - mdpi.com
Hepatocarcinogenesis is a complex multistep process in which many different molecular
pathways have been implicated. Hepatocellular carcinoma (HCC) is refractory to …
pathways have been implicated. Hepatocellular carcinoma (HCC) is refractory to …
EGFR has a tumour-promoting role in liver macrophages during hepatocellular carcinoma formation
H Lanaya, A Natarajan, K Komposch, L Li… - Nature cell …, 2014 - nature.com
Hepatocellular carcinoma (HCC) is a frequent cancer with limited treatment options and
poor prognosis. Tumorigenesis has been linked with macrophage-mediated chronic …
poor prognosis. Tumorigenesis has been linked with macrophage-mediated chronic …
Role of epidermal growth factor receptor in liver injury and lipid metabolism: Emerging new roles for an old receptor
B Bhushan, GK Michalopoulos - Chemico-biological interactions, 2020 - Elsevier
Epidermal growth factor receptor (EGFR) is conventionally known to play a crucial role in
hepatocyte proliferation, liver regeneration and is also associated with hepatocellular …
hepatocyte proliferation, liver regeneration and is also associated with hepatocellular …
[PDF][PDF] Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis
E Schiffer, C Housset, W Cacheux, D Wendum… - …, 2005 - Wiley Online Library
Epidermal growth factor receptor (EGFR) binds transforming growth factor α (TGF‐α) which
is mitogenic for hepatocytes. Diverse lines of evidence suggest that activation of the TGF …
is mitogenic for hepatocytes. Diverse lines of evidence suggest that activation of the TGF …
Targeting the epidermal growth factor receptor by gefitinib for treatment of hepatocellular carcinoma
M Höpfner, AP Sutter, A Huether, D Schuppan… - Journal of …, 2004 - Elsevier
BACKGROUND/AIMS: Hepatocellular carcinoma (HCC) is one of the most common cancer-
related causes of death worldwide. Due to very poor 5-year-survival new therapeutic …
related causes of death worldwide. Due to very poor 5-year-survival new therapeutic …
[PDF][PDF] Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the most rapidly increasing cause of cancer‐related
mortality in the United States. Because of the lack of viable treatment options for HCC …
mortality in the United States. Because of the lack of viable treatment options for HCC …